BiotechTube
Home/MindImmune Therapeutics/Stevin Zorn, PhD
SZ

Stevin Zorn, PhD

Chief Science Officer

MindImmune Therapeutics

Therapeutic Areas

Alzheimer's DiseaseNeurodegenerative Diseases

MindImmune Therapeutics Pipeline

DrugIndicationPhase
MITI-101Alzheimer's DiseasePreclinical

Leadership Team at MindImmune Therapeutics

IS
Isaac Stoner
Chief Executive Officer
View full MindImmune Therapeutics profile